Sébastien Weibel1, Rosetta Nicastro2, Paco Prada2, Pierre Cole2, Eva Rüfenacht2, Eléonore Pham2, Alexandre Dayer3, Nader Perroud3. 1. Department of Psychiatry, University Hospital of Strasbourg, Strasbourg, France; Department of Mental Health and Psychiatry, University Hospitals of Geneva, Geneva, Switzerland. Electronic address: weibelse@gmail.com. 2. Department of Mental Health and Psychiatry, University Hospitals of Geneva, Geneva, Switzerland. 3. Department of Mental Health and Psychiatry, University Hospitals of Geneva, Geneva, Switzerland; Department of Psychiatry, University of Geneva, Geneva, Switzerland.
Abstract
BACKGROUND: A valid screening instrument is needed to detect attention-deficit/hyperactivity disorder (ADHD) in treatment-seeking borderline personality disorder (BPD) patients. We aimed to test the performance of the widely-used Adult ADHD Self-Report Scale v1.1 screener (ASRS-v1.1). METHODS: 317 BPD subjects were systematically assessed for comorbid ADHD and completed the ASRS-v1.1. 79 BPD patients also completed the Wender Utah Rating Scale (WURS-25). RESULTS: The prevalence of adult ADHD was of 32.4%. The overall positive predictive value of the ASRS-v1.1 was of 38.5%, the negative predictive value 77.0%, the sensitivity 72.8%, and the specificity 43.9%. Combining WURS-25 and ASRS-v1.1 improved sensitivity to 81.8% and specificity to 59.6%. LIMITATIONS: Cross-sectional study on treatment-seeking patients. CONCLUSIONS: We found a high prevalence of ADHD using structured interviews. The ASRS-v1.1 was not a sensitive screener for identifying possible ADHD cases in a BPD population, with a high number of false positives. When combined with the WURS-25, it offered improved screening.
BACKGROUND: A valid screening instrument is needed to detect attention-deficit/hyperactivity disorder (ADHD) in treatment-seeking borderline personality disorder (BPD) patients. We aimed to test the performance of the widely-used Adult ADHD Self-Report Scale v1.1 screener (ASRS-v1.1). METHODS: 317 BPD subjects were systematically assessed for comorbid ADHD and completed the ASRS-v1.1. 79 BPD patients also completed the Wender Utah Rating Scale (WURS-25). RESULTS: The prevalence of adult ADHD was of 32.4%. The overall positive predictive value of the ASRS-v1.1 was of 38.5%, the negative predictive value 77.0%, the sensitivity 72.8%, and the specificity 43.9%. Combining WURS-25 and ASRS-v1.1 improved sensitivity to 81.8% and specificity to 59.6%. LIMITATIONS: Cross-sectional study on treatment-seeking patients. CONCLUSIONS: We found a high prevalence of ADHD using structured interviews. The ASRS-v1.1 was not a sensitive screener for identifying possible ADHD cases in a BPD population, with a high number of false positives. When combined with the WURS-25, it offered improved screening.
Authors: Enrico Capuzzi; Martina Capellazzi; Alice Caldiroli; Francesca Cova; Anna Maria Auxilia; Paola Rubelli; Ilaria Tagliabue; Francesco Giuseppe Zanvit; Gianluca Peschi; Massimiliano Buoli; Massimo Clerici Journal: Healthcare (Basel) Date: 2022-01-18
Authors: Natalia Calvo; Benjamin Lara; Laia Serrat; Violeta Pérez-Rodríguez; Òscar Andión; Josep A Ramos-Quiroga; Marc Ferrer Journal: Borderline Personal Disord Emot Dysregul Date: 2020-01-06